A detailed history of Ronald Blue Trust, Inc. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 123 shares of BGNE stock, worth $22,024. This represents 0.0% of its overall portfolio holdings.

Number of Shares
123
Previous 48 156.25%
Holding current value
$22,024
Previous $6,000 350.0%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$143.93 - $224.51 $10,794 - $16,838
75 Added 156.25%
123 $27,000
Q2 2024

Jul 18, 2024

BUY
$129.52 - $174.32 $4,403 - $5,926
34 Added 242.86%
48 $6,000
Q1 2024

May 01, 2024

SELL
$141.8 - $181.47 $7,231 - $9,254
-51 Reduced 78.46%
14 $2,000
Q4 2023

Jan 18, 2024

BUY
$158.67 - $201.58 $5,236 - $6,652
33 Added 103.13%
65 $11,000
Q3 2023

Oct 11, 2023

BUY
$179.87 - $225.13 $1,798 - $2,251
10 Added 45.45%
32 $6,000
Q2 2023

Jul 14, 2023

SELL
$178.3 - $266.78 $26,210 - $39,216
-147 Reduced 86.98%
22 $5,000
Q1 2023

Apr 17, 2023

BUY
$215.53 - $274.5 $27,372 - $34,861
127 Added 302.38%
169 $37,000
Q4 2022

Jan 17, 2023

BUY
$125.51 - $229.3 $5,145 - $9,401
41 Added 4100.0%
42 $6,000
Q3 2022

Oct 21, 2022

SELL
$131.8 - $202.24 $2,899 - $4,449
-22 Reduced 95.65%
1 $0
Q2 2022

Aug 09, 2022

BUY
$121.11 - $216.05 $2,785 - $4,969
23 New
23 $4,000

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $18.6B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.